News
-
-
-
-
PRESS RELEASE
THX PHARMA (THERANEXUS) AND EXELTIS ACHIEVE KEY MILESTONE TOWARDS THE COMMERCIALIZATION OF TX01
THX Pharma (Theranexus) and Exeltis achieve key milestone towards the commercialization of TX01 for rare neurological diseases, including Gaucher and Niemann-Pick type C. A pivotal step towards regulatory submission and global launch -
-
-
PRESS RELEASE
EuroTeleSites Reports Revenue Increase to mEUR 70.5 and an EBITDAaL Margin of 58.3% in Q3/2025
EuroTeleSites AG reports revenue increase to mEUR 70.5 with EBITDAaL margin of 58.3% in Q3/2025 driven by tower construction and third-party relationships, maintaining stable growth performance -
-
-
PRESS RELEASE
Salzgitter AG launches a EUR 500 million offering of bonds exchangeable for shares of Aurubis AG
Salzgitter AG launches a EUR 500 million offering of bonds exchangeable for shares of Aurubis AG. Proceeds for business purposes and restructuring measures. Bonds issued on 22 October 2025 with a maturity of seven years
